Scene 1 (0s)
. . tAåer:a1 'Plate.Jers •.
Scene 2 (7s)
. . F&ateuerr.
Scene 3 (13s)
. . Complete—evacut- crate pl VI fed Loss o too.
Scene 4 (19s)
. . ADP # rom bin.
Scene 5 (26s)
. . in Cok4blp-..
Scene 6 (32s)
. . 1 sjr_ÄQ2.
Scene 7 (38s)
. . Tea fvmen+ u Cog ——Antiplat-ele€—•—— Aqpirir) inhibi+Pon COY J 7 — /ö dcu./s TXA COX itor • TXAt 4.
Scene 8 (47s)
. . ptatel? Dore dose P*0bleens jn ATP ADP CA+Z p e.FAre in • i or Claudiccc+öon Ciloshæcb phosphßJ,'Qß+emse 'nh;bj+ø 3 rD-Jf J-aA.J.
Scene 9 (56s)
. . a rteyies inhibit ADP %irre.veQhW'i inhibi+ ADP binding re.ve.CibPb Ticlopjo%ne-- ( (75m') clo edoqreA ( Less e ) ciOPl'd03reJ ihromb04JfoPemqd neutropema.
Scene 10 (1m 5s)
. . e effet+ . d; 4-9 Fibrinogen Jl rocppf0h a oøue e.vtø O we Ia.'u IS ev+ennon VSes•,.
Scene 11 (1m 15s)
. . Direct Factors Heparin 1.
Scene 12 (1m 21s)
. . e—-réd.osttae vit K re ad vit e ctottrrg - Fact-or.
Scene 13 (1m 28s)
. . ae.PGrin 0 1 % B(eedhrx 00-1-4 k e— Antiddt? c-r_z, nega-t-n.e- antidote.
Scene 14 (1m 38s)
. . wayfar$n Sicte eßßectt ppl effect.
Scene 15 (1m 44s)
. . gen ic 10).
Scene 16 (1m 50s)
. . Dece Gdjus+rnewtt —Recen-ü4ntäC0A9ulan+—Dyu s ( Sußßöx thrombin yom b kid,npq bound.
Scene 17 (1m 57s)
. . rayp«-.'l 04dø•us.
Scene 18 (2m 4s)
. . 2 mote specific than QC.
Scene 19 (2m 10s)
. . Tranexamtc aca. hechnnjrrn 1' Yinø 17717 Qnd von willebrand.